Position in JNJ
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$7,054,778
+$309,701 QoQ
Shares Held
27,778
+0.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.71%
of 13F equity value
Holder Rank
#1,341
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Atwater Malick LLC holds $12,919,723 across 8 Drug Manufacturers - General names. JNJ ranks #1 (54.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
27,778 | $7,054,778 | |
| 2 | NVO |
Novo Nordisk A S
|
57,670 | $2,764,699 | |
| 3 | LLY |
ELI LILLY & Co
|
1,015 | $1,217,421 | |
| 4 | ABBV |
AbbVie Inc.
|
3,342 | $840,980 | |
| 5 | MRK |
Merck & Co., Inc.
|
2,527 | $324,719 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,245 | $283,633 | |
| 7 | AMGN |
Amgen Inc
|
644 | $233,205 | |
| 8 | NVS |
Novartis AG
|
1,278 | $200,288 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,054,778 | 27,778 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $6,745,077 | 27,594 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $6,541,896 | 31,611 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $6,888,909 | 37,153 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $7,484,139 | 48,996 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $8,074,417 | 48,688 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $6,900,543 | 47,715 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $8,127,633 | 50,152 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $7,284,614 | 49,840 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $7,982,741 | 50,463 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $7,813,959 | 49,853 | Shares | Sole | 2024-01-11 | |
| 2023-09-30 | $7,631,905 | 49,001 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $7,817,675 | 47,231 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $7,124,420 | 45,964 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $7,901,731 | 44,731 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $7,095,541 | 43,435 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $7,514,175 | 42,331 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $7,391,377 | 41,705 | Shares | Sole | 2022-04-08 | |
| 2021-12-31 | $6,880,093 | 40,218 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $6,275,728 | 38,859 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $6,181,374 | 37,522 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $5,818,811 | 35,405 | Shares | Sole | 2021-05-21 | |
| 2020-12-31 | $5,894,195 | 37,452 | Shares | Sole | 2021-01-20 | |
| 2020-09-30 | $5,463,896 | 36,700 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $5,038,069 | 35,825 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $4,595,450 | 35,045 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||